Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Phase 3 Psoriasis Trials

12 Phase 3 trials for Psoriasis. Phase 3 trials are the final stage of testing before a treatment can be submitted for FDA approval.

What is a Phase 3 trial?

Phase 3 clinical trials study a treatment in large groups (hundreds to thousands of people) to confirm its effectiveness, monitor side effects, and compare it to standard treatments. These trials are the last major step before the FDA considers approving a new treatment.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
RECRUITINGPhase 3NCT06641089

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

This is a study to confirm the clinical efficacy and safety of sonelokimab compared with placebo in the treatment of adults with active psoriatic arthritis who have had a previous...

Sponsor: MoonLake Immunotherapeutics AGEnrolling: 60020 locations
RECRUITINGPhase 3NCT06100744

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With...

Psoriatic arthritis (PsA) is a type of arthritis that happens when the body's immune system attacks healthy cells and tissues causing joint pain, stiffness, and swelling. Symptoms...

Sponsor: AbbVieEnrolling: 4020 locations
RECRUITINGPhase 3NCT06425549

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6...

The primary purpose of this study is to evaluate the efficacy of bimekizumab administered subcutaneously (sc) compared to active control (ustekinumab) in children and adolescents...

Sponsor: UCB Biopharma SRLEnrolling: 16820 locations
RECRUITINGPhase 3NCT06937060

Effect of Semaglutide in Patients With Psoriasis and Obesity

Obesity is well known to be an important comorbidity of psoriasis. It gives rise to higher risk of psoriatic arthritis, more severe disease and also poorer response to biologics....

Sponsor: The University of Hong KongEnrolling: 141 location
RECRUITINGPhase 3NCT06671496

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well...

Sponsor: TakedaEnrolling: 60020 locations
RECRUITINGPhase 3NCT07357831

A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque...

This is a multi-center, randomized, investigator-blinded, calcipotriol and betamethasone dipropionate gel and vehicle-controlled phase 3 clinical study to evaluate the efficacy...

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Enrolling: 53720 locations
RECRUITINGPhase 3NCT07426120

Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris...

The goal of this clinical trial is to learn if a botanical Total Coumarin topical cream (TC Cream) works to treat psoriasis in adults. It will also learn about the safety of the...

Sponsor: Psoriasis Research Institute of GuangzhouEnrolling: 3001 location
RECRUITINGPhase 3NCT06842199

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

This is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study to evaluate the efficacy, safety, PK characteristics of ICP-488 in Chinese adults with...

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.Enrolling: 38320 locations
RECRUITINGPhase 3NCT05669833

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

The trial is an open-label randomized study that will examine whether switching to a selective IL23 inhibitor (guselkumab) is more effective than switching to a second TNFi...

Sponsor: University of PennsylvaniaEnrolling: 6314 locations
RECRUITINGPhase 3NCT07286058

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

Psoriatic arthritis (PsA) is a long-term inflammatory disease that affects the joints and skin. The purpose of this study is to check how safe zasocitinib is, how well it is...

Sponsor: TakedaEnrolling: 11821 location
RECRUITINGPhase 3NCT06640257

A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis

This study is a randomized, double-blind, multicenter, placebo-controlled Phase III clinical study, consisting of a 4-week screening period, a 24-week core treatment period, a...

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.Enrolling: 2001 location
RECRUITINGPhase 3NCT07029516

Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis

A randomized, double blind, placebo-controlled, unicenter, parallel group study to assess the efficacy, safety and tolerability of a multi-funtion toe nail patch in patients...

Sponsor: Wooshin Labottach Co., Ltd.Enrolling: 721 location